Apollomics, Inc. APLM NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Apollomics, Inc. (APLM) has a negative trailing P/E of -0.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -189.51%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.5); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -189.51%).
Trailing Earnings Yield -189.51% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 43/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

46/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✓

FUTURE

100/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

22/100

→ Income

GROWTH

58/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — APLM

Valuation Multiples

P/E (TTM)-0.5

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio-3.74

P/S Ratio2.38

EV/EBITDA-0.5

Per Share Data

EPS (TTM)$-28.28

Book Value / Share$-3.99

Revenue / Share$6.28

FCF / Share$-11.56

Yields & Fair Value

Earnings Yield-189.51%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2019	-18.7	0.00	-14.15	0.00	-
2020	-11.5	0.00	-6.72	467.51	-
2021	-9.1	-0.68	-4.05	430,941.15	-
2022	-3.7	-0.02	-2.01	2,783.91	-
2023	-0.4	0.00	1.74	87.45	-
2024	-0.2	0.00	1.86	45.62	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2019	$-0.53	$0.00	$-45.91M	-
2020	$-0.86	$1.84M	$-74.82M	-4070.7%
2021	$-1.09	$2K	$-94.8M	-4739850%
2022	$-2.77	$323K	$-240.81M	-74554.5%
2023	$-2.32	$821K	$-172.6M	-21023.3%
2024	$-52.80	$0.00	$-53.86M	-

Analyst Estimates

Year	EPS (Avg)	EPS Range	Revenue (Avg)	Revenue Range	Analysts
2026	$-122.00	$-122.00 – $-122.00	$222.71K	$222.71K – $222.71K	1
2027	$-138.00	$-138.00 – $-138.00	$236.2K	$236.2K – $236.2K	1
2028	$-138.00	$-138.00 – $-138.00	$12.8M	$12.8M – $12.8M	1